Detalles de la búsqueda
1.
Persistent Hypogammaglobulinemia after Receiving Rituximab Post-HSCT Is Not Caused by an Intrinsic B Cell Defect.
Int J Mol Sci
; 24(21)2023 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37958995
2.
Cysteine and hydrophobic residues in CDR3 serve as distinct T-cell self-reactivity indices.
J Allergy Clin Immunol
; 144(1): 333-336, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31053347
3.
Advances in gene therapy for inborn errors of immunity.
Curr Opin Allergy Clin Immunol
; 23(6): 467-477, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37846903
4.
Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying Rag1 hypomorphic mutations.
Front Immunol
; 14: 1268620, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38022635
5.
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content.
Front Immunol
; 8: 798, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28769923
6.
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content.
Front Immunol
; 8: 1244, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29042861
7.
Novel Genome-Editing Tools to Model and Correct Primary Immunodeficiencies.
Front Immunol
; 6: 250, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26052330
Resultados
1 -
7
de 7
1
Próxima >
>>